Cardiovascular disease costs the UK economy £29 billion a year

NewsGuard 100/100 Score

Cardiovascular disease costs the UK economy £29 billion a year in healthcare expenditure and lost productivity, reveals research published ahead of print in Heart.

The UK spends more of its healthcare budget on cardiovascular disease than any other country in the European Union, the figures show.

The research team from the Health Economics Research Centre at the University of Oxford base their calculations on all UK residents with diagnosed cardiovascular disease in 2004 and associated costs.

These included community health and social services, emergency care, hospital stays, informal care, and the impact on productivity from illness and premature death.

When all these factors were added up, the total costs to the UK economy of cardiovascular disease in 2004 came to £29 billion.

The largest component was healthcare, which accounted for 60% of the total. Lost productivity accounted for 23% and informal care cost 17%.

Cardiovascular disease and cost the NHS almost £16 billion in 2004, representing 21% of all healthcare expenditure. Private healthcare costs add almost £1.5 billion to the tally, representing 18% of overall UK healthcare costs.

These figures represent the highest proportion of healthcare expenditure on cardiovascular disease of any country in the European Union.

Hospital inpatient care was the most expensive component at almost £10 billion or nearly two thirds of the NHS bill for cardiovascular disease.. Drug costs amounted to almost £3 billion.

More than 69 million work days were lost to the disease in 2004, at a cost to the UK economy of almost £3 billion.

An accompanying editorial suggests that despite the falling rates of illness and death from cardiovascular disease, cost savings are likely to be cancelled out by the rising costs of treatment, the ageing of the population, and the threat to heart health posed by obesity and diabetes

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Risk of non-alcoholic fatty liver disease for cardiovascular disease and all cause death in patients with type 2 diabetes mellitus